Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

890
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
890
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

469
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
469

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yoga Nidra Versus Music Therapy for Sleep and Mental Well-being in Post-COVID-19 Hospitalised Patients: A Three-arm Randomised Controlled Trial.

Annals of neurosciences·2026
Same author

Chemical Analysis of Native Himalayan Shilajit: An Evaluation of an Ayurvedic Formulation.

ACS omega·2025
Same author

Metronidazole-induced encephalopathy and polyneuropathy.

BMJ case reports·2025
Same author

Possible Terbinafine and/or Itraconazole Induced Vasculitis - A Case Study.

Current drug safety·2024
Same author

Primary Sjogren's syndrome presenting as hypokalaemic periodic paralysis and acute pancreatitis.

BMJ case reports·2024
Same author

Pseudomonas and aspergillus symbiotic coinfections in a case of chronic obstructive pulmonary disease and diabetes mellitus.

BMJ case reports·2024

Related Experiment Video

Updated: Jan 8, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.1K

Unmasking tuberculosis triggered IgA nephropathy.

Amit Kumar1, Pooja Maheshwari2, Prasan Kumar Panda3

  • 1Internal Medicine (ID Division), All India Institute of Medical Sciences-Rishikesh, Rishikesh, Uttarakhand, India.

BMJ Case Reports
|December 15, 2025
PubMed
Summary
This summary is machine-generated.

Tuberculosis-triggered IgA nephropathy (TB-IgAN) is a rare kidney disease. Early identification of TB-related renal involvement is crucial for managing IgA nephropathy.

Keywords:
Acute renal failureImmunologyInfectious diseasesProteinurea

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.2K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

839

Related Experiment Videos

Last Updated: Jan 8, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.1K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

2.2K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

839

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • Tuberculosis-triggered IgA nephropathy (TB-IgAN) is an uncommon renal complication of tuberculosis.
  • It often presents with non-specific symptoms, leading to delayed diagnosis.

Purpose of the Study:

  • To report a case of TB-IgAN in a young woman.
  • To emphasize the importance of considering renal involvement in tuberculosis patients.

Main Methods:

  • Case report of a woman in her 30s with symptoms of kidney disease and cough.
  • Diagnostic workup including urinalysis, pulmonary evaluation for Mycobacterium tuberculosis (MTB), and kidney biopsy.
  • Histopathological examination of the kidney biopsy.

Main Results:

  • The patient was diagnosed with pulmonary tuberculosis and biopsy-confirmed IgA nephropathy (IgAN).
  • The findings confirmed TB-IgAN as the cause of her rapidly progressive kidney disease.
  • Kidney biopsy, though challenging with active MTB, was essential for diagnosis.

Conclusions:

  • TB-IgAN requires a high index of suspicion in patients with tuberculosis and renal symptoms.
  • Early detection of TB-related renal complications can significantly impact IgAN management.
  • MTB can trigger immune-mediated renal diseases like IgAN, necessitating thorough evaluation.